Skip to content

Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair

Comparing the Effectiveness of Blood Flow Restriction Therapy Versus Standard Exercise After Arthroscopic Rotator Cuff Repair: Protocol for the Multicenter S-TRONGER Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06788327
Acronym
S-TRONGER
Enrollment
50
Registered
2025-01-23
Start date
2025-03-03
Completion date
2027-08-31
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury, Rotator Cuff Repair, Rotator Cuff Tears

Keywords

blood flow restriction therapy, blood flow restriction training

Brief summary

The goal of this clinical trial is to determine the effectiveness of postoperative standard exercises with blood flow restriction therapy (BFRT) versus standard exercises alone on shoulder muscle strength and mass in participants with surgically treated rotator cuff tear. It is presumed that the addition of BFRT will significantly improve the shoulder strength and muscle mass at the end of the intervention period compared to the group receiving only standard exercises. Patients who agree to participate in this research will be randomly assigned to a control group (standard exercises alone) or an experimental group (standard rehabilitation with BFRT). The duration of the postoperative intervention will be 12 weeks. The primary variables will be the shoulder muscle strength and muscle mass. Secondary variables will be the active shoulder mobility, pain intensity, upper limb disability, and health-related quality of life. Results will be measured at 0, 4 and 12 weeks postoperative.

Interventions

OTHERStandard rehabilitation

Protocol based on the best available evidence and to be used in all participants in both groups. The standard exercises protocol will consist of three postoperative rehabilitation phases: phase I (weeks 1 to 4), phase II (weeks 5 to 8) and phase III (weeks 9 to 12). Sessions will be held 2 times a week for 12 weeks. Each session will last 45 minutes and will consist of six exercises in the phase I, eight exercises in phase II, and eight exercises in phase III.

DEVICEBlood Flow Restriction Therapy

Participants will perform three exercises of the standard exercises protocol with BFRT. An auto-regulated portable BFRT SmartCuffs® 3.0 Pro system with a 17-inch long and 5-inch-wide cuff (Smart Tools Plus, United States), placed on the most proximal part of the arm, will be used. Each BFRT session will begin with a maximal occlusion test to personalize the occlusion pressure to the participant. The limb occlusion pressure (LOP) will be set at 50% of the maximum occlusion pressure in the first stage and 60% in stages II and III. The participant will perform 75 repetitions per BFRT exercise divided into 4 sets (30, 15, 15, and 15 repetitions). The load intensity during the BFRT exercises will be set near to 3 out of 10 on the Borg's CR10 scale (weak), which corresponds to 30% of a 1RM effort. After each exercise, the cuff will be deflated, and the patient will rest for two minutes.

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Opaque sealed envelopes

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 40-65 years * Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging * Undergoing arthroscopic rotator cuff repair * Be able to read and understand Spanish

Exclusion criteria

* Massive irreparable rotator cuff tear * Concomitant fracture * Labral or nerve injury * Suspicious of developing a frozen shoulder * Revision surgery after rotator cuff repair * Previous corticosteroid injection (\< 6 months) * Recent surgery (\< 1 year) in the contralateral shoulder * History of deep venous thrombosis/pulmonary embolism, peripheral vascular disease, thrombophilia or clotting disorders * Severe or uncontrolled hypertension, or any comorbid condition that impedes participants to complete the intervention

Design outcomes

Primary

MeasureTime frameDescription
Shoulder muscle strength0, 4 and 12 weeksShoulder abduction and external rotation maximum voluntary isometric strength will be measured using dynamometry (kilograms)
Shoulder muscle mass0, 4 and 12 weeksSupraspinatus and long head biceps brachii tendon thickness will be measured using ultrasound imaging (milimeters)

Secondary

MeasureTime frameDescription
Pain intensity0, 4 and 12 weeksVisual Analogue Scale (0 to 10 centimeters)
Self-reported upper limb disability0, 4 and 12 weeksShoulder Pain Disability Index (0 to 100%)
Self-reported quality of life0, 4 and 12 weeksWestern Ontario Rotator Cuff Index (0 to 100%)
Active Range of Motion0, 4 and 12 weeksShoulder flexion, abduction, and external rotation will be measured with a goniometer (degrees)

Countries

Chile

Contacts

Primary ContactJosé Casaña, PhD
jose.casana@uv.es+34656437371
Backup ContactFelipe Ponce-Fuentes, MSc
felipe.poncef@umayor.cl+56954411974

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026